Filana Therapeutics, Inc. (FLNA): Revenue
Older than the company's other figures. The latest Revenue is for the year ended 2013-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$41.12M
Year ended 2013-12-31
+34.7%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2013-12-31 | $41.12M | +277.6% | 2016-03-03, From 2013-01-01 |
| 2012-12-31 | $10.89M | -5.2% | 2015-02-18, From 2012-01-01 |
| 2011-12-31 | $11.48M | -31.7% | 2014-02-05, From 2011-01-01 |
| 2010-12-31 | $16.81M | -18.3% | 2013-02-08, From 2010-01-01 |
| 2009-12-31 | $20.56M | n/a | 2012-02-09, From 2009-01-01 |